Edition:
United Kingdom

XBiotech Inc (XBIT.OQ)

XBIT.OQ on NASDAQ Stock Exchange Global Select Market

4.12USD
10 Dec 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$4.12
Open
$4.15
Day's High
$4.15
Day's Low
$4.12
Volume
522
Avg. Vol
22,291
52-wk High
$5.80
52-wk Low
$2.13

Chart for

About

XBiotech Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in discovering and developing True Human monoclonal antibodies for treating a range of different diseases. It focuses on its lead product candidate, Xilonix (MABp1), which is derived from a natural human immune response. The Company has also... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $157.97
Shares Outstanding(Mil.): 35.42
Dividend: --
Yield (%): --

Financials

  XBIT.OQ Industry Sector
P/E (TTM): -- 92.25 33.63
EPS (TTM): -1.47 -- --
ROI: -62.28 0.28 15.02
ROE: -62.30 0.94 16.60

Earnings vs. Estimates